Identity recordFDA-flagged unapproved research-market peptide identity
What DSIP / Emideltide resolves to
DSIP, also called emideltide or delta sleep-inducing peptide, is tracked here as a US research-market identity. FDA has identified emideltide among bulk substances that may present significant safety risks in compounding and notes important gaps in human safety information. That does not establish an approved medicine, a lawful local supply route, seller identity, product quality, or suitability for use in any destination.
- Evidence lane
- Research price board
- Current record
- 2 of 3 rows in stock
- Checked
- Jul 23, 2026
Delta sleep-inducing peptideEmideltideDSIP nonapeptidedelta sleep-inducing peptidedelta sleep inducing peptide
Destination recordHSA product and e-pharmacy checks
What Singapore still has to prove
A Singapore guide to checking peptide-related offers through HSA's therapeutic-product register, licensed dealer and retail-pharmacy searches, and e-pharmacy requirements.
- Comparison mode
- SGD / HSA product, dealer, and pharmacy records
- Price coverage
- No qualified Singapore seller table
- Guide updated
- July 18, 2026